Catena Biosciences
Berkeley, CA
Catena Biosciences is a biotech startup based on research from the Francis and Doudna labs at UC Berkeley focusing on the treatment and cure of autoimmune disorders. Catena’s platform differentiates on the ability to fuse proteins together using enzyme activation of native amino acids to create new treatments in oncology, autoimmune disorders and vaccine development!
catenabiosciences.comCompany Details
Founded
- 2020
Employees
- Between 5 - 20 employees
Raised
- $8,050,000
Headquarters Location
- Berkeley, CA
Public
- No
Acquired
- No
CEO
Marco Lobba
Founders
- Matt FrancisMarco LobbaGregorio (Geo) Guillen
Company Collections
These are collections Catena Biosciences is a part of. Click on the collection name to view similar companies.
Catena Biosciences' Investors
Catena Biosciences' Industries
Catena Biosciences Headquarters Location
Berkeley, CA 94710
Total Amount Raised: $8,050,000
Catena Biosciences' Investors
Catena Biosciences Funding Rounds
Seed
$2,350,000
Seed Investors
FreeflowCalifornia Innovation FundPioneer FundCivilization VenturesCaffeinated CapitalBrightEdge - American Cancer SocietyLongeVCSeed
$5,000,000
Seed Investors
Social Impact CapitalReinforced VenturesMBX CapitalGaingelsIaso VenturesAmgenOutset CapitalCalifornia Innovation FundPioneer FundPre Seed
$700,000
Pre Seed Investors
Social Impact CapitalCivilization VenturesY Combinator
Funding info provided by Diffbot.
Catena Biosciences Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Catena Biosciences.